Risk of developing diabetic nephropathy is not associated with synergism between the angiotensin II (type 1) receptor C1166 allele and poor glycaemic control.


Autoria(s): Fogarty, Damian
Data(s)

1999

Identificador

http://pure.qub.ac.uk/portal/en/publications/risk-of-developing-diabetic-nephropathy-is-not-associated-with-synergism-between-the-angiotensin-ii-type-1-receptor-c1166-allele-and-poor-glycaemic-control(e966d3b5-2880-4c08-a8f9-80c684f4659d).html

http://www.scopus.com/inward/record.url?scp=0032891635&partnerID=8YFLogxK

Idioma(s)

eng

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

Fogarty , D 1999 , ' Risk of developing diabetic nephropathy is not associated with synergism between the angiotensin II (type 1) receptor C1166 allele and poor glycaemic control. ' Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association , vol 14(4) , no. 4 , pp. 891-894 .

Palavras-Chave #/dk/atira/pure/subjectarea/asjc/2700/2727 #Nephrology #/dk/atira/pure/subjectarea/asjc/2700/2747 #Transplantation
Tipo

article